AAAAAA
Results: 1-25/27
Authors:
Hirsch, FR
Osterlind, K
Jeppesen, N
Dombernowsky, P
Ingeberg, S
Sorensen, PG
Kristensen, C
Hansen, HH
Citation: Fr. Hirsch et al., Superiority of high-dose platinum (cisplatin and carboplatin) compared to carboplatin alone in combination chemotherapy for small-cell lung carcinoma: A prospective randomised trial of 280 consecutive patients, ANN ONCOL, 12(5), 2001, pp. 647-653
Authors:
Hansen, HH
Daugaard, G
Citation: Hh. Hansen et G. Daugaard, Management of carcinoma of unknown primary site (CUP), any changes?, ANN ONCOL, 12(4), 2001, pp. 431-432
Authors:
Gronlund, B
Hogdall, C
Hansen, HH
Engelholm, SA
Citation: B. Gronlund et al., Results of reinduction therapy with paclitaxel and carboplatin in recurrent epithelial ovarian cancer, GYNECOL ONC, 83(1), 2001, pp. 128-134
Authors:
Hansen, HH
Schmid, PC
Bittigau, P
Lastres-Becker, I
Berrendero, F
Manzanares, J
Ikonomidou, C
Schmid, HHO
Fernandez-Ruiz, JJ
Hansen, HS
Citation: Hh. Hansen et al., Anandamide, but not 2-arachidonoylglycerol, accumulates during in vivo neurodegeneration, J NEUROCHEM, 78(6), 2001, pp. 1415-1427
Authors:
Hansen, HH
Ikonomidou, C
Bittigau, P
Hansen, SH
Hansen, HS
Citation: Hh. Hansen et al., Accumulation of the anandamide precursor and other N-acylethanolamine phospholipids in infant rat models of in vivo necrotic and apoptotic neuronal death, J NEUROCHEM, 76(1), 2001, pp. 39-46
Authors:
Niederhoffer, N
Hansen, HH
Fernandez-Ruiz, JJ
Szabo, B
Citation: N. Niederhoffer et al., Effects of cannabinoids on adrenaline release from adrenal medullary cells, BR J PHARM, 134(6), 2001, pp. 1319-1327
Authors:
Nielsen, SE
Zeuthen, J
Lund, B
Persson, B
Alenfall, J
Hansen, HH
Citation: Se. Nielsen et al., Phase I study of single, escalating doses of a superantigen-antibody fusion protein (PNU-214565) in patients with advanced colorectal or pancreatic carcinoma, J IMMUNOTH, 23(1), 2000, pp. 146-153
Authors:
Sorensen, M
Jensen, PB
Herrstedt, J
Hirsch, FR
Hansen, HH
Citation: M. Sorensen et al., A dose escalating study of topotecan preceding cisplatin in previously untreated patients with small-cell lung cancer, ANN ONCOL, 11(7), 2000, pp. 829-835
Authors:
Hansen, HH
Citation: Hh. Hansen, Maurizio Tonato - ESMO President 1999-2001, ANN ONCOL, 11(4), 2000, pp. 377-377
Authors:
Klee, MC
King, MT
Machin, D
Hansen, HH
Citation: Mc. Klee et al., A clinical model for quality of life assessment in cancer patients receiving chemotherapy, ANN ONCOL, 11(1), 2000, pp. 23-30
Authors:
Hansen, HH
Citation: Hh. Hansen, Limited small-cell lung cancer: A potentially curable disease, ONCOLOGY-NY, 14(10), 2000, pp. 1404
Authors:
Motta, G
Hansen, HH
Citation: G. Motta et Hh. Hansen, Welcome to a new year, LUNG CANC, 27(1), 2000, pp. 1-2
Authors:
Carney, DN
Hansen, HH
Citation: Dn. Carney et Hh. Hansen, Non-small-cell lung cancer - Stalemate or progress?, N ENG J MED, 343(17), 2000, pp. 1261-1262
Authors:
Hansen, HH
Hansen, SH
Schousboe, A
Hansen, HS
Citation: Hh. Hansen et al., Determination of the phospholipid precursor of anandamide and other N-acylethanolamine phospholipids before and after sodium azide-induced toxicity in cultured neocortical neurons, J NEUROCHEM, 75(2), 2000, pp. 861-871
Authors:
Hansen, HS
Moesgaard, B
Hansen, HH
Petersen, G
Citation: Hs. Hansen et al., N-acylethanolamines and precursor phospholipids - relation to cell injury, CHEM PHYS L, 108(1-2), 2000, pp. 135-150
Authors:
Hansen, HH
Hansen, SH
Bjornsdottir, I
Hansen, HS
Citation: Hh. Hansen et al., Electrospray ionization mass spectrometric method for the determination ofcannabinoid precursors: N-acylethanolamine phospholipids (NAPEs), J MASS SPEC, 34(7), 1999, pp. 761-767
Authors:
Sorensen, JB
Stenbygaard, LE
Dombernowsky, P
Hansen, HH
Citation: Jb. Sorensen et al., Paclitaxel, gemcitabine, and cisplatin in non-resectable non-small-cell lung cancer, ANN ONCOL, 10(9), 1999, pp. 1043-1049
Authors:
Hansen, HH
Bjerre-Jepsen, M
Hossfeld, D
Citation: Hh. Hansen et al., The European Society for Medical Oncology (ESMO) and its activities through the Central Eastern European Task Force, ANN ONCOL, 10, 1999, pp. 9-13
Authors:
Schleisner, C
Norgaard, P
Hansen, HH
Citation: C. Schleisner et al., Discriminant analysis of patterns of jaw movement during rumination and eating in a cow, ACT AG SC A, 49(4), 1999, pp. 251-259
Authors:
Jensen, PB
Sehested, M
Langer, SW
Hansen, HH
Citation: Pb. Jensen et al., Twenty-five years of chemotherapy in small cell lung cancer sends us back to the laboratory, CANC TR REV, 25(6), 1999, pp. 377-386
Authors:
Lassen, U
Hansen, HH
Citation: U. Lassen et Hh. Hansen, Surgery in limited stage small cell lung cancer, CANC TR REV, 25(2), 1999, pp. 67-72
Authors:
Hansen, HH
Citation: Hh. Hansen, Oleg S. Selawry, MD - 21 February 1924-12 February 1999 - In memoriam, LUNG CANC, 26(1), 1999, pp. 1-2
Authors:
Hansen, HH
Citation: Hh. Hansen, IASLC teaching courses, LUNG CANC, 24(2), 1999, pp. 123-124
Authors:
Hansen, HH
Citation: Hh. Hansen, Lung cancer - A status report, LUNG CANC, 23(1), 1999, pp. V-V
Authors:
Hansen, HS
Moesgaard, B
Hansen, HH
Schousboe, A
Petersen, G
Citation: Hs. Hansen et al., Formation of N-acyl-phosphatidylethanolamine and N-acylethanolamine (including anandamide) during glutamate-induced neurotoxicity, LIPIDS, 34, 1999, pp. S327-S330